Scientific Research and Advances in Cancer Therapy - Genetic TOE

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This edition of the Genetic TOE depicts the current landscape and the new life sciences trends across cancer therapy. In particular, next generation cancer therapies, novel targets and genetic technologies, and personalized vaccines have been profiled. The corresponding patent scenario is depicted along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies;

Table of Contents

Scientific Research and Advances in Cancer Therapy - Genetic TOETechnology ProfilesNext Generation Cancer TherapyNovel Cancer Therapy TargetsNovel microRNA Gene TherapyPersonalized Vaccines for CancerAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.